Figures
Abstract
Background
We observed visual sensations (VSs) in patients undergoing intensity modulated radiotherapy (IMRT) of the brain without the beam passing through ocular structures. We analyzed this phenomenon especially with regards to reproducibility, and origin.
Methods and Findings
Analyzed were ten consecutive patients (aged 41-71 years) with glioblastoma multiforme who received pulsed IMRT (total dose 60Gy) with helical tomotherapy (TT). A megavolt—CT (MVCT) was performed daily before treatment. VSs were reported and recorded using a triggered event recorder. The frequency of VSs was calculated and VSs were correlated with beam direction and couch position. Subjective patient perception was plotted on an 8x8 visual field (VF) matrix. Distance to the orbital roof (OR) from the first beam causing a VS was calculated from the Dicom radiation therapy data and MVCT data. During 175 treatment sessions (average 17.5 per patient) 5959 VSs were recorded and analyzed. VSs occurred only during the treatment session not during the MVCTs. Plotting events over time revealed patient-specific patterns. The average cranio-caudad extension of VS-inducing area was 63.4mm (range 43.24-92.1mm). The maximum distance between the first VS and the OR was 56.1mm so that direct interaction with the retina is unlikely. Data on subjective visual perception showed that VSs occurred mainly in the upper right and left quadrants of the VF. Within the visual pathways the highest probability for origin of VSs was seen in the optic chiasm and the optic tract (22%).
Citation: Wilhelm-Buchstab T, Buchstab BM, Leitzen C, Garbe S, Müdder T, Oberste-Beulmann S, et al. (2015) Extraretinal Induced Visual Sensations during IMRT of the Brain. PLoS ONE 10(4): e0123440. https://doi.org/10.1371/journal.pone.0123440
Academic Editor: Kevin Camphausen, NIH, UNITED STATES
Received: January 30, 2015; Accepted: March 3, 2015; Published: April 15, 2015
Copyright: © 2015 Wilhelm-Buchstab et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Data Availability: All relevant data are within the paper.
Funding: The authors have no support or funding to report.
Competing interests: The authors have declared that no competing interests exist.
Introduction
There is a long history of reports of visual sensations (VSs) caused by radiation, under various circumstances [1–4]. For example, VSs were reported by astronauts during the Apollo mission space flights [5–11]; it was suggested that Cherenkov radiation [12] or direct interaction of radiation particles, as protons, heavy ions or neutrons with the retina were responsible [13–21]. Even though one might have the impression that occurrence of VSs is completely understood, especially with regards to their origin, this is not the case. We observed VSs in a patient undergoing stereotactic IMRT for a single brain metastasis under circumstances in which direct interaction with the retina was improbable [22]. This study was intended to further elucidate this finding and test the hypothesis that radiation- induced VS may be of extraocular origin.
Methods
The study protocol was approved by the local ethical review committee: Ethikkommission der Rheinischen Friedrich Wilhelm-Universität Bonn. All participants had to pass a consent procedure and had to provide their written declaration of consent (approved by the ethical review committee) before they were included in this study.
The study included 10 patients, all of whom had reported light flashes during their first radiation treatment. All patients suffered from WHO Grade IV glioma and received image guided helical intensity modulated radiotherapy (IMRT) with a Tomotherapy Hi Art System (TT). The 3 women and 7 men were between 41 and 71 years of age. Nine of the ten patients underwent adjuvant combined radio-chemotherapy (Temozolomid or Bevacizumab) after surgery; one received primary radio-chemotherapy. Five patients were on anticonvulsive medication (Levetirazepam). All patients were positioned on a positioning board (All in one, Orfit) in a supine position for radiation treatment. A three-point thermoplastic head fixation mask (Orfit) was used to ensure that the head was positioned in a stable and comfortable position. Daily Megavoltage Computed Tomography (MVCT) was matched to the planning computed tomography, and the table was adjusted manually to ensure that the patient was positioned correctly before irradiation. Radiotherapy was delivered using a 25 mm (n = 9) or 10 mm (n = 1) beam size with a pitch of 0.43. Patients received a total dose of 60 Gy in daily fractions of 2Gy.
Patients were allowed to keep their eyes open or closed during treatment, and their choice was recorded.
Event registration and analysis
An event recorder was placed in the right hand of the patients and they were instructed to press a push button whenever they experienced a VS. Events were recorded with a digital audio editor (audacity 1.2.6) during all treatment sessions i.e. during radiation therapy and during the preceding MVCT.
After radiation treatment the patients were asked to describe their visual sensations in detail (color, shape, brightness, intensity etc.) and indicate their location on a visual field diagram.
Information on beam angle, leaf opening time and table position was extracted from the radiation treatment planning (RTP) file. This allowed us to analyze the beam characteristics, specifically the beam path, at the times VSs were recorded. The orbital roof was used as a reference point. To make a distinction between a radiation beam which could affect the optic pathways (or not) in relation to bony anatomic structures a point in a distance of half a beam width above the highest point of the orbital roof was found best in all patients. We were able to differentiate VSs caused by supraorbital beam paths from events which occurred when the orbits and optic pathways were in line with the path of the treatment beam.
Converting Dicom (Digital Imaging and communications in Medicine) data to NIfTI (Neuroimaging Informatics Technology Initiative) format transformation to standardized brain magnetic resonance tomography (MRI) images was possible by using mricron (version 6/2013, NITRC, Chris Rorden) and evildicom library (Rex Cardan, version 0.0.5.7, http://www.rexcardan.com/evildicom/). Using ANTS (Advanced normalization tools software by PICSL (Penn Image Computing & Science Lab) affine transformation of planning CT to standardized MRI was possible. As we observed that VSs occurred only during treatment mode (and not during the preceding CT, see below) we defined a threshold to eliminate beams which deposit a dose > 1% to the retina; in this way all beams closer than 40 mm to the eyeballs were eliminated.
Furthermore we correlated beam path with the incidence of VSs, and evaluated their frequency along the extra- and intracerebral visual pathways. All parts of the visual apparatus, including eyes, optic nerves, chiasma, optical tract, optic radiation and Brodman areas 17, 18, 19, 20, 21, 31 were defined in standardized MRI image, and a probability estimation for the origin of the VSs was performed.
Results
All patients who had reported VSs during their first treatment session (the inclusion criterion) also reported VSs during the subsequent 29 treatments.
There were no reports of VSs during daily pre-treatment MVCT scans.
Data from 175/290 (60.3%) treatment fractions were analyzed; data from 115 treatment sessions were discarded for various technical reasons such as malfunction of the event recorder, broken cables etc.
5959 VSs were registered during the 175 analyzed sessions.
In total, we analyzed 97285 different beams, on average 580 (359–877) beams per session (Table 1).
Patients reported VSs of white and blue colored light flashes, or arc-shaped light formations, sometimes moving from left to right, or right to left. Three patients described vessel-like light contours. Analysis of the 8x8 visual field matrix demonstrated that VS were mainly assigned to the upper left or right visual fields (Fig 1).
Summation of all perceptions independent from primary tumor site (a). Perception of visual sensations divided in patients with right (b) and left sided tumor location (c). Visual sensations were mainly projected in the upper right or left and the central visual field but not in the lower parts suitable for the majority of the beams. No relationship between primary tumor site and location of light perception can be made. Interestingly most beams were located supraorbital. However the main VSs were registered in the upper visual field and not, as expected in the lower quadrants.
The VSs were recorded in all subsequent evaluable treatment sessions by all patients and occurred regardless of whether the patient’s eyes were open or shut. Although the reported intensity was lower when eyes were open. The correlation of the events and the beam paths revealed that 5.9% of all beams (5959 of 97285 beams) induced VSs. 4% (2970 of 74460 beams) of supraorbital beam paths induced VSs, while beams below the orbital roof induced VSs in 13,1% (2989/22825). In any given patient the beam path parameters associated with VSs were remarkably constant. There were patient-specific patterns associated with occurrence and absence of VSs. These patterns were consistent over all treatment sessions (Fig 2). The elimination of all beams causing VSs passing the eyes closer than 40 mm allowed us to discriminate intracerebral regions along the optical tract which seem to be responsible for VSs other than orbital structures (Fig 3).
Position of orbital roof is marked with a red dashed line. Every patient showed a pattern, which indicates that the VSs are induced by specific beam paths.
The different frequency can be seen in the colored bar. (a) Exposed brain areas during all 175 treatment sessions. Most beams were located in the center of the brain. (b) All beams passing the eyeballs in a distance > 4cm, so that direct beam path did not hit the eyeballs. (c) All beams which induced a visual sensation. Highest frequency is seen in the mid brain and temporal lobe, less in the occipital lobe, least in the parietal brain areas. (d) All beams passing the eyes in a distance > 4 cm inducing a visual sensation. Direct interaction of radiation with the retina is impossible for these visual perceptions. This anatomic correlation shows a high frequency along the intracerebral visual pathways.
Anatomic correlation of all beam paths affecting the visual pathways with the incidence of VSs revealed probabilities for being the origin of VSs as demonstrated in Table 2.
We evaluated the doses in the extraretinal visual pathways (optic chiasm and optic nerve) which showed highest probability for being the origin of the VSs (Table 3). The maximum shielding of the eyeballs resulted in low doses in the optical nerves and an increased dose in the optic chiasm.
The mean distance between planning target volume (PTV) and the nearest eyeball was 44.4mm (16.7–76.0mm).
Correlating the measurements with the MVCT data allowed a calculation of the longitudinal distance between the first registered light sensation and the orbital roof as a reference structure (Table 4); the maximum recorded distance was 56 mm; the average over all patients was 29 mm.
Discussion
The phenomenon of radiation-induced VSs has long been recognized [1, 3, 23]. Descriptions of the color and shape of the light phenomena are consistent in reports over the decades, but the phenomenon is still poorly understood. It is scientifically accepted that the blue light flashes are induced by direct irradiation of the retina, for example during space flights [4–18] in dark adapted eyes.
Observing VSs in a patient undergoing radiation treatment with a Tomotherapy unit caused us to further elucidate this finding in a group of patients who were treated for glioblastoma. The study tried to objectify subjective perceptions of patients during their radiation treatment. As patients were encluded, when they experienced VS during radiotherapy, it was not a randomized study, and we were not able to compare our results with a control group.
As visual sensations in patients undergoing tomotherapy treatment of brain tumors have neither been systematically reported nor evaluated, we had to compare our findings with VS occurring under other conditions.
In contrast to former reports on visual sensations, e.g. those occurring in astronauts, in our study VSs occurred regardless of whether the patient’s eyes were open or shut under roomlight conditions.
Correlation of VSs and beam parameters of the therapy unit revealed that the conditions under which VSs were recorded, were remarkably reproducible. This was the case not only within one treatment session but also between treatment sessions. Neither the position of the linac nor the beam path during occurrence of a VS was known by the patient.
Former publications discussing VSs lack information about the location of the light perception in the visual field. As illustrated in our results most beams triggering VS were located above the eye level (74460 / 97285). Assuming that radiation induces VSs by direct interaction with the retina, this should affect mainly upper retinal tissue, and consequently lead to phenomena in the lower visual field. However, our patients reported exactly the opposite, describing moving light sensations in the upper visual field. This means, nerval structures that usually carry information from lower retinal receptors to the visual cortex are responsible for the VS, further supporting the hypothesis of an extraretinal VSs origin.
The maximum vertical beam path distance to the orbital roof at the time of the first VS was 56 mm in our patients. Under such a condition radiation scattering causes only a very small dose reaching the intraorbital structures, as the dose fall-off with tomotherapy is steep: In a distance of 30mm from the treatment volume the dose is less than 1% of the prescribed dose [24]. With such small doses, induction of VSs seems improbable comparable to the results of Schardt et al. [25, 26].
In a second step of our analysis including all administered beams we were able to assign probabilities for VSs to occur in visual pathways.
Analyzing all beams, i.e. not excluding beams affecting the eyes, it turned out, that 20% of the beams affected the eyes, and only 10% of those induced VSs. On the contrary 22.3% of the beams passing structures as optic tract or the chiasma induced light perceptions. All analyzed Brodman areas showed a higher incidence of VSs than the eyes themselves. These results also support our thesis of extraretinal, retroorbital origin.
The dose exposition of optic nerves and optic chiasm shows a high variability with a wide range (from 2% to107% of the prescribed dose). There seems to be no obvious correlation between doses and the induction of visual sensations.
Our hypothesis seems to be supported by recent reports of VSs in two patients undergoing heavy ion therapy for skull base tumors [25, 26]. The authors described VSs even in the absence of detectable dose deposition in the eye. Cherenkov radiation was considered unlikely to account for VSs in these patients as the dose did not exceed the typical Cherenkov radiation threshold of 430 MeV/n; the authors did not offer a definitive explanation or point of origin for the VSs in these cases.
VSs occurred despite the fact that we maximally avoided direct beam paths through the orbits. Virtually shielding the eyes from the radiation by excluding all beams closer than 40 mm to the center of the nearest eyeball showed highest probability for being the origin of VSs (15%) for beams in a distance more than 40 mm occipital to the optic chiasm (Fig 3d).
VSs were unlikely to be due to radiation leakage: it has been demonstrated that because of the pronounced collimator shielding radiation leakage amounts to less than 0.05% of the administered dose [24]. If radiation leakage or scattering were responsible for VSs the phenomenon should be observed more frequently during conventional radiotherapy, which is associated with much more scattering and leakage of radiation.
The mechanism of radiation induced VSs by exciting extraocular intracerebral neuronal centers may be explained by molecular physiological studies. They suggest that radiation-induced increases in cell excitability are caused by depolarization processes in the neuronal tissue. The effects of radiation-induced free radicals (i.e. TNF-α) on microglial tissue and astrocytes should also be considered [27–30]. All these processes may play a role in VSs and should be investigated further.
In summary, this study analyzed 10 photon irradiated brain tumor patients who experienced VSs during Tomotherapy radiation treatment. We evaluated 97285 beams and over 5959 VSs registered during 175 treatment sessions. Highest probability for being the origin of VSs was shown for optic chiasm, optic tract and along the extraretinal visual pathways. To further localize anatomic regions in future, a larger number of patients as well as smaller target volumes, like in stereotactic irradiation, will be necessary.
Author Contributions
Conceived and designed the experiments: TWB BMB HS. Performed the experiments: TWB BMB HS CL SG SOB FS TM. Analyzed the data: TWB BMB HS TM HS. Contributed reagents/materials/analysis tools: AMS BS MN WB. Wrote the paper: TWB HHS.
References
- 1. Brandes G, Dorn E (1897) Über die Sichtbarkeit der Röntgenstrahlen. Wiedemann′s Annal d Physik u Chemie; 60: 478–490
- 2. Gangloff H, Hug O (1965) The effects of ionizing radiation on the nervous system. Adv Biol Med Phys 10: 1–90 pmid:5321884
- 3. Lipetz J (1955) The next X-ray and radium phosphenes. Br J Ophtalmol 39: 577–598 pmid:13260555
- 4. Schober H (1964) Direct perception of x-rays by the human eye. Vision Res 4: 251–269 pmid:4866415
- 5. Chapman P, Pinsky L Benson R, Budinger T (1972) Proc. Nat Symp. Natural and Manmade Radiation in Space. NASA TN X-2440: 1102.
- 6. Charman WN, Dennis JA, Fazio GG, Jelley JV (1971) Visual sensations produced by single fast particles. Nature 230: 522–524 pmid:4927751
- 7. Charman WN, Rowlands CM (1971) Visual sensations produced by cosmic ray muons. Nature 232: 574–575 pmid:4937506
- 8. D´Arcy FJ, Porter NA (1962) Detection of cosmic ray mesons by the human eye. Nature 196: 1013–1014 pmid:14024986
- 9. Fazzio GG, Jelly JV, Charman WN (1970) Generation of Cherenkov light flashes by cosmic radiation within the eyes of Apollo astronauts. Nature 228: 260–264 pmid:5479522
- 10. Pinsky LS, Osborne WZ, Bailey JV, Benson RE, Thompson LF (1974) Light flashes observed by astronauts on Apollo 11 through Apollo 17. Science 183: 957–959 pmid:17756755
- 11. Sannita WG, Narici L, Picozza P (2006) Positive visual phenomena in space: A scientific case and a safety issue in space travel. Vision Res 46: 2159–2165 pmid:16510166
- 12. Bachofer CS, Wittry SE (1963) Immediate retinal response to x-rays at milliroentgen levels. Radiat Res 18: 246–254 pmid:13965918
- 13. Cherenkov P (1964) Radiation of particles moving at a velocity exceeding that of light, and some of the possibilities for their use in experimental physics. Nobel Lectures, Physics 1942–1962 3: 426–440
- 14. De Vries KD, van den Berg A M, Scholten O, Werner K (2011) Coherent Cherenkov radiation from cosmic-ray-induced air showers. Phys Rev Lett 2011; 061101-1- 061101-5
- 15. Newman F, Asadi-Zeydabadi M, Durairaj VD, Ding M, Stuhr K, Kavanagh B (2008) Visual sensations during megavoltage radiotherapy to the orbit attributable to Cherenkov radiation. Med Phys 35: 77–80 pmid:18293564
- 16. Steidley KD, Eastman RM, Stabile RJ (1989) Observations of visual sensation produced by Cerenkov radiation from high-energy electrons. Int J Radiat Oncol Biol Phys 17: 685–690 pmid:2506161
- 17. Steidley KD (1990) The radiation phosphene. Vision Res 30:1139–1143 pmid:2205976
- 18. Fuglesang C, Narici L, Picozza P, Sannita WG (2006) Phosphenes in low earth orbit: Survey responses from 59 astronauts. Aviation, Space, and Environmental Medicine 77: 449–452 pmid:16676658
- 19. McNulty PJ, Pease VP, Pinsky LS, Bond VP, Schimmerling W, Vosburgh KG (1972) Visual sensations induced by relativistic nitrogen nuclei. Science 178: 160–162 pmid:5076904
- 20.
Tobias CA, Budinger TF, Lyman JT (1970) Observations by human subjects on radiation induced light flashes In Fast neutron, X-ray and positive pion beams. LBL: Berkley, p. 16. pmid:4928670
- 21. Tobias CA, Budinger TF, Lyman JT (1971) Radiation-induced light flashes observed by human subjects in fast neutron, X-ray and positive pion beams. Nature 230: 596–598 pmid:4928670
- 22.
Wilhelm-Buchstab T, Leitzen C, Garbe S, Müdder TH, Lütter C, Schoroth F, et al. (2013) Visual light sensations during stereotactic IMRT of brain metastasis. 30 Jahrestagung der Österreichischen Gesellschaft für Radioonkologie, Radiobiologie und Medizinische Radiophysik 65: Schardt D,
- 23. Edison TA (1896) Recent roentgen ray observations. Electrical engineer 22: 520
- 24. Jeraj R, Mackie TR, Balog J, Olivera G, Pearson D, Kapatoes J, et al. (2004) Radiation characteristics of helical tomotherapy. Med Phys 31:396–404 pmid:15000626
- 25. Krämer M (2012) Particle induced visual sensations in heavy-ion tumor therapy. GSI Biophysics.
- 26. Schardt D, Kavatsyuk O, Krämer M, Durante M (2012) Light flashes in cancer patients treated with heavy ions. Brain Stimul 6: 416–417 pmid:22939278
- 27. Bókkon I (2008) Phosphene phenomenon: A new concept. BioSystems 92: 168–174 pmid:18358594
- 28. Clatworthy AL, Noel F, Grose E, Cui M, Tofilon PJ (1999) Ionizing radiation-induced alterations in the electrophysiological properties of Aplysia sensory neurons. Neurosci Lett 268: 45–48 pmid:10400074
- 29. Jenrow KA, Ratkewicz AE, Elisevich KV (2001) Enhanced excitability induced by ionizing radiation in kindled rat. Exp Neurol 16: 96–104
- 30. Chiang CS, McBright WH (1991) Radiation enhances tumor necrosis factor alpha production by murine brain cells. Brain Res 566: 256–269